APA (7th ed.) Citation

Rustgi, S. D., Oh, A., Yang, J. Y., Kang, D., Wolin, E., Kong, C. Y., . . . Hur, C. (2021). Initiation of Somatostatin analogues for neuroendocrine tumor patients: A cost-effectiveness analysis. BMC Cancer, 21(1), 1. https://doi.org/10.1186/s12885-021-08306-5

Chicago Style (17th ed.) Citation

Rustgi, Sheila D., et al. "Initiation of Somatostatin Analogues for Neuroendocrine Tumor Patients: A Cost-effectiveness Analysis." BMC Cancer 21, no. 1 (2021): 1. https://doi.org/10.1186/s12885-021-08306-5.

MLA (9th ed.) Citation

Rustgi, Sheila D., et al. "Initiation of Somatostatin Analogues for Neuroendocrine Tumor Patients: A Cost-effectiveness Analysis." BMC Cancer, vol. 21, no. 1, 2021, p. 1, https://doi.org/10.1186/s12885-021-08306-5.